Erika Kjellberg-Eriksson
Voorzitter bij Q-LINEA AB
Profiel
Erika Elisabeth Kjellberg-Eriksson is currently the Chief Executive Officer at Nexttobe AB since 2011.
She is also the Chairman at Eurofins Genomics Europe Genotyping A, Q-linea AB, Linum AB, Bioimics AB, Lokon Pharma AB, AllgoHolding AB, Capilet Genetics AB, Tanea Medical AB, Navinci Diagnostics AB, Bluefish Pharmaceuticals AB, Sweden Carnica Group AB, Lumina Adhesives AB, Vivolux AB, The Delta Projects AB, Findolon AB, Bluefish Pharma Incentive AB, and Brixton Medical AB.
Previously, Erika held the position of Chairman at Qvestor AB and Director at A+ Science Holding AB.
She was also the Chief Executive & Financial Officer at BioPhausia AB from 1997 to 1999 and the Chief Financial Officer at OxThera AB from 2008 to 2011.
Erika completed her undergraduate degree at the University of Uppsala in 1985.
Actieve functies van Erika Kjellberg-Eriksson
| Bedrijven | Functie | Begin |
|---|---|---|
| Q-LINEA AB | Voorzitter | 01-01-2018 |
| Lokon Pharma AB | Voorzitter | - |
Eurofins Genomics Europe Genotyping A/S
 Eurofins Genomics Europe Genotyping A/S Pharmaceuticals: MajorHealth Technology Part of Eurofins Scientific SE, Eurofins Genomics Europe Genotyping A/S is a Danish company that provides genomic solutions for the development of new drugs. The company is based in Aarhus, Denmark. Eurofins Genomics Europe Genotyping was acquired by Eurofins Scientific SE on February 21, 2013. | Voorzitter | - |
Brixton Medical AB
 Brixton Medical AB Agricultural Commodities/MillingProcess Industries Brixton Medical AB breeds horses and other equine animals. The private company is based in Stockholm, Sweden. The CEO of the Swedish company is Daniel Redén. | Directeur/Bestuurslid | - |
| Linum AB | Voorzitter | - |
| Bluefish Pharma Incentive AB | Corporate Officer/Principal | - |
| Findolon AB | Directeur/Bestuurslid | - |
Vivolux AB
 Vivolux AB BiotechnologyHealth Technology Vivolux AB develops biotechnology for anticancer drugs. The private company is based in Gothenburg, Sweden. | Directeur/Bestuurslid | - |
The Delta Projects AB
 The Delta Projects AB Advertising/Marketing ServicesCommercial Services Part of Principion Holding BV, The Delta Projects AB is a company that provides advertising services. The company is based in Stockholm, Sweden. The Delta Projects was acquired by Principion Holding BV on July 01, 2021. The CEO of the Swedish company is John Marcus Boson Lilja. | Directeur/Bestuurslid | - |
| ░░░░░░ ░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Eerdere bekende functies van Erika Kjellberg-Eriksson
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░ ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Erika Kjellberg-Eriksson
| University of Uppsala | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| Q-LINEA AB | Health Technology |
| Bedrijven in privébezit | 21 |
|---|---|
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Distribution Services |
Bluefish Pharmaceuticals AB
 Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
Eurofins Genomics Europe Genotyping A/S
Eurofins Genomics Europe Genotyping A/S Pharmaceuticals: MajorHealth Technology Part of Eurofins Scientific SE, Eurofins Genomics Europe Genotyping A/S is a Danish company that provides genomic solutions for the development of new drugs. The company is based in Aarhus, Denmark. Eurofins Genomics Europe Genotyping was acquired by Eurofins Scientific SE on February 21, 2013. | Health Technology |
A+ Science Holding AB
 A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
| Linum AB | |
Sweden Carnica Group AB
 Sweden Carnica Group AB Specialty TelecommunicationsCommunications Sweden Carnica Group AB develops and offers consultancy and research services within the information technology sector. It also provides assistance in broadband, applications, and Video on Demand. The company is headquartered in Gavle, Sweden. | Communications |
Lumina Adhesives AB
 Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Process Industries |
Vivolux AB
Vivolux AB BiotechnologyHealth Technology Vivolux AB develops biotechnology for anticancer drugs. The private company is based in Gothenburg, Sweden. | Health Technology |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
| Qvestor AB | |
| Bioimics AB | |
The Delta Projects AB
The Delta Projects AB Advertising/Marketing ServicesCommercial Services Part of Principion Holding BV, The Delta Projects AB is a company that provides advertising services. The company is based in Stockholm, Sweden. The Delta Projects was acquired by Principion Holding BV on July 01, 2021. The CEO of the Swedish company is John Marcus Boson Lilja. | Commercial Services |
| Lokon Pharma AB | |
| Findolon AB | |
| AllgoHolding AB | |
| Capilet Genetics AB | |
| Tanea Medical AB | |
| Bluefish Pharma Incentive AB | |
Brixton Medical AB
Brixton Medical AB Agricultural Commodities/MillingProcess Industries Brixton Medical AB breeds horses and other equine animals. The private company is based in Stockholm, Sweden. The CEO of the Swedish company is Daniel Redén. | Process Industries |
Navinci Diagnostics AB
 Navinci Diagnostics AB BiotechnologyHealth Technology Navinci Diagnostics AB is a Swedish biotech company that specializes in innovative proximity ligation assay-based solutions for spatial proteomics. Navinci Diagnostics is based in Uppsala County, SE. The company's resources section offers a variety of instructions, protocols, informative whitepapers, and scientific posters. The CEO of the company is Carl Robert Gunnarsson. | Health Technology |
